Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 6,589 | 2,235 | 5,199 | 0 | 0 |
| Gross Profit | 6,589 | 2,235 | 5,199 | N/A | N/A |
| Operating Expenses | 144,726 | 148,781 | 139,030 | 94,883 | 53,898 |
| Operating Income | -138,137 | -146,546 | -133,831 | -94,883 | -53,898 |
| Interest Expense | 0 | 540 | 1,430 | 1,275 | 381 |
| Other Income | 13,361 | 12,294 | 4,420 | 377 | 704 |
| Pre-tax Income | -124,776 | -134,792 | -130,841 | -95,781 | -53,575 |
| Income Tax | 1,790 | 1,881 | 91 | 43 | N/A |
| Net Income Continuous | -126,566 | -136,673 | -130,932 | -95,824 | -53,575 |
| Net Income | $-126,566 | $-136,673 | $-130,932 | $-95,824 | $-53,575 |
| EPS Basic Total Ops | -1.61 | -2.30 | -2.27 | -2.96 | -7.16 |
| EPS Basic Continuous Ops | -1.61 | -2.30 | -2.27 | -2.96 | -7.16 |
| EPS Diluted Total Ops | -1.61 | -2.30 | -2.27 | -2.96 | -7.16 |
| EPS Diluted Continuous Ops | -1.61 | -2.30 | -2.27 | -2.96 | -7.16 |
| EPS Diluted Before Non-Recurring Items | -1.61 | -2.08 | -2.27 | -2.96 | N/A |
| EBITDA(a) | $-129,645 | $-137,392 | $-125,092 | $-90,829 | $-52,404 |